Renal Cell Cancer Clinical Trials

A listing of Renal Cell Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

Scottsdale Arizona 85258

A clinical research study of Avelumab (MSB0010718C) and Axitinib (AG-013736) for the treatment of Renal Cell Cancer, Advanced

California

Duarte California 91010

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

La Jolla California 92093

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

La Jolla California 92037

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Santa Monica California 90403

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Colorado

Aurora Colorado 80045

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Aurora Colorado 080045

Patients are needed to participate in a clinical research study of IMMU-132

Connecticut

New Haven Connecticut 06511

Patients are needed to participate in a clinical research study of IMMU-132

Delaware

Newark Delaware 19713

Patients are needed to participate in a clinical research study of IMMU-132

District of Columbia

Washington District of Columbia 20007

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Florida

Orlando Florida 32806

Patients are needed to participate in a clinical research study of IMMU-132

Indiana

Goshen Indiana 46526

Patients are needed to participate in a clinical research study of IMMU-132

Maryland

Bethesda Maryland 20892

Patients are needed to participate in a clinical research study evaluating hetIL-15 for the treatment of Skin Melanoma, Renal Cell Cancer, Non-Small Cell Lung Cancer or Head and Neck Squamous Cell Carcinoma

Massachusetts

Boston Massachusetts 02114

Patients are needed to participate in a clinical research study of IMMU-132

Michigan

Detroit Michigan 48201

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Detroit Michigan 48202

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

New York

East Setauket New York 11733

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

New York New York 10032

Patients are needed to participate in a clinical research study of IMMU-132

New York New York 10021

Patients are needed to participate in a clinical research study of IMMU-132

Ohio

Columbus Ohio 43210

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Tennessee

Nashville Tennessee 37212

Patients are needed to participate in a clinical research study of IMMU-132

Texas

Dallas Texas 75246

Patients are needed to participate in a clinical research study of IMMU-132

Washington

Seattle Washington 98109

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Seattle Washington 98111

Patients are needed to participate in a clinical research study of IMMU-132

Belgium

UPDATED

Brussels

A Phase 1 clinical study for patients with Renal Cell Cancer

Canada

UPDATED

Kirkland Quebec H9H 3L1

A Phase 1 clinical study for patients with Renal Cell Cancer

Germany

Freiburg

A clinical trial to evaluate treatments for patients with Renal Cell Carcinoma

United Kingdom

Edinburgh

A clinical trial to evaluate treatments using ImmuniCell® for patients with Malignant Melanoma, Non-small Cell Lung Cancer or Renal Cell Cancer, Advanced Cancers

Glasgow

A clinical trial to evaluate treatments using ImmuniCell® for patients with Malignant Melanoma, Non-small Cell Lung Cancer or Renal Cell Cancer, Advanced Cancers

London SW3 6JJ

A clinical research study of Avelumab (MSB0010718C) and Axitinib (AG-013736) for the treatment of Renal Cell Cancer, Advanced

Manchester M20 4BX

A clinical research study of Avelumab (MSB0010718C) and Axitinib (AG-013736) for the treatment of Renal Cell Cancer, Advanced